Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.44 |
| ▸ | GABRP | O00591 | 1/20 | 0.44 |
| ▸ | GABRD | O14764 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.44 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL562061 | 1.00 | GSR (0.46) | GSRLMNAGABRR1THRBBLM | |
| SCHEMBL159650 | 1.00 | GSR (0.46) | GSRLMNAGABRR1THRBBLM | |
| SCHEMBL60354 | 1.00 | GSR (0.46) | GSRLMNAGABRR1THRBBLM | |
| Ammonia Solution, Strong SCHEMBL8677036 | 0.98 | GSR (0.45) | GSRLMNAGABRR1THRBBLM | |
| Hydrochloric Acid SCHEMBL31510869 | 0.98 | GSR (0.45) | GSRLMNAGABRR1THRBBLM | |
| SCHEMBL30514395 | 0.93 | GSR (0.56) | GSRLMNAGABRR1THRBBLM | |
| SCHEMBL284983 | 0.93 | GSR (0.56) | GSRLMNAGABRR1THRBBLM | |
| SCHEMBL289144 | 0.93 | GSR (0.56) | GSRLMNAGABRR1THRBBLM | |
| Propionic Acid SCHEMBL29234998 | 0.92 | S1PR2 (0.45) | GSRLMNAGABRR1THRBBLM | |
| SCHEMBL288798 | 0.91 | GSR (0.54) | GSRLMNAGABRR1THRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250180578-A1 | METHODS FOR IDENTIFYING MODIFICATIONS OF A POLYPEPTIDE | NAUTILUS SUBSIDIARY INC (US) | 2025-06-05 | — | — | US | claimed |
| CN-119409964-A | Epsilon-poly-L-lysine derivative with click function, preparation method and application thereof | 公立大学法人福井县立大学 | 2025-02-11 | — | — | CN | claimed |
| US-20240402186-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE QUANTITATION | NAUTILUS SUBSIDIARY INC (US) | 2024-12-05 | — | — | US | claimed |
| CN-118125936-A | N-acyl ethanolamide derivative, preparation method and application thereof | 南京清普生物科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| EP-4096715-A1 | COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF | Flagship Pioneering Innovations VI, LLC (US) | 2022-12-07 | — | — | EP | claimed |
| US-20220305128-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2022-09-29 | — | — | US | claimed |
| EP-3986469-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF | Flagship Pioneering Innovations VI, LLC (US) | 2022-04-27 | — | — | EP | claimed |
| WO-2021155177-A1 | COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2021-08-05 | — | — | WO | claimed |
| WO-2020257730-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2020-12-24 | — | — | WO | claimed |
| CN-107913246-A | The medical composite for eye of local administration | 刘力 | 2018-04-17 | — | — | CN | claimed |
| US-20120301950-A1 | BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS | CELEXION, LLC | 2012-11-29 | — | — | US | claimed |
| CN-102124119-A | Production process for fine chemicals using microorganisms with reduced isocitrate dehydrogenase activity | BASF SE | 2011-07-13 | — | — | CN | claimed |
| US-20100184210-A1 | METHOD FOR ISOLATING CELLS | MERCK PATENT GESELLSCHAFT (DE) | 2010-07-22 | — | — | US | claimed |
| EP-2049677-A1 | METHOD FOR ISOLATING CELLS | MERCK PATENT GmbH (DE) | 2009-04-22 | — | — | EP | claimed |
| CN-101400799-A | Method for producing beta-lysine | BASF SE (DE) | 2009-04-01 | — | — | CN | claimed |
| WO-2008017097-A1 | METHOD FOR ISOLATING CELLS | MERCK PATENT GMBH (DE) | 2008-02-14 | — | — | WO | claimed |
| WO-2007047680-A2 | INCREASING THE ACTIVITY OF RADICAL S-ADENOSYL METHIONINE (SAM) ENZYMES | CARGILL, INCORPORATED (US) | 2007-04-26 | — | — | WO | claimed |
| EP-0134563-B1 | NOVEL AMINOGLYCOSIDE COMPOUNDS AND THEIR ACID ADDITION SALTS AND PROCESS FOR PRODUCTION THEREOF | KOWA COMPANY, LTD. (JP) | 1988-10-19 | — | — | EP | claimed |
| US-4647656-A | ANTIBIOTICS | KOWA COMPANY, LTD. (JP) | 1987-03-03 | — | — | US | claimed |
| EP-0134563-A1 | Novel aminoglycoside compounds and their acid addition salts and process for production thereof | KOWA COMPANY, LTD. (JP) | 1985-03-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220305128-A1 | COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF | RNMT, NSUN3, NSUN2 | GSR 3278/4885LMNA 1365/4885GABRR1 2572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.